Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment model for gene-based sickle cell anemia treatments, the agency announced ...

Abstract: This study addresses the high-frequency limitations of conventional single-resonance models for induction magnetometers (IMs) with magnetic flux negative feedback. At frequencies beyond the ...

Abstract: A novel resonance model is formulated to evaluate the resonance properties of frequency-selective surfaces (FSSs) using characteristic modes (CMs). This CM-based resonance model, derived ...

Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...

CellDiffusion provides a generalized implementation of diffusion models for single-cell RNA sequencing data. It allows users to generate synthetic virtual cells from AnnData objects, providing a ...

This important work combines theoretical analysis with precise experimental perturbation to demonstrate that the Wnt signaling pathway is characterized by anti-resonance, or a suppression of pathway ...

TEMPE, Ariz.--(BUSINESS WIRE)--#SPRmicroscopy--Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR ...

Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy technology first launched in 2017, the ...

Scientists from the Massachusetts Institute of Technology (MIT) have developed the first publicly available model for predicting the long-term stability of a cell type commonly used in biotherapeutic ...

Lineage Cell Therapeutics has found an experienced hearing loss partner to advance a potentially novel transplant for auditory neurons. William Demant Invest, the largest shareholder of Danish hearing ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell ...

The Centers for Medicare and Medicaid Services (CMS) has selected 35 participants for its new, voluntary Cell and Gene Therapy Access Model. Participants include the District of Columbia, Puerto Rico ...